Trial intelligence / Profile preview

PATCH

2005-001030-33Phase 2Unknown

Sponsor
University College London
Start
Aug 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of FemSeven, estradiol in prostate cancer (PCa), sponsored by University College London. Status: unknown.

02

Drugs

FemSevenestradiol
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on 2005-001030-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001030-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call